Skip to main content
Erschienen in: Osteoporosis International 12/2005

01.12.2005 | Original Article

The aluminum content of bone increases with age, but is not higher in hip fracture cases with and without dementia compared to controls

verfasst von: Hans-Olov Hellström, Bengt Mjöberg, Hans Mallmin, Karl Michaëlsson

Erschienen in: Osteoporosis International | Ausgabe 12/2005

Einloggen, um Zugang zu erhalten

Abstract

Aluminum is considered a potentially toxic metal, and aluminum poisoning may lead to three types of disorders: aluminum-induced bone disease, microcytic anemia and encephalopathy. This is well known in patients with chronic renal failure, but since healthy subjects with normal renal function retain 4% of the aluminum consumed, they are also at risk of long-term low-grade aluminum intoxication. Included in this study were a total of 172 patients (age range 16–98 years) with the aim of examining whether aluminum accumulates in bone with increasing age. Additionally, we aimed to investigate whether the aluminum content of bone differs between controls and hip fracture cases with and without dementia, in particular in those with Alzheimer’s disease. During operations for all cases, bone biopsies were taken with an aluminum-free instrument from the trabecular bone. The samples were measured for their content of aluminum using an inductively coupled mass spectrometer. We found an exponential increase in aluminum content of bone with age. The average aluminum values, adjusted for age, were similar in men and women (P=0.46). No significant differences in sex- and age-adjusted mean aluminum values between the controls and the hip fracture cases with (P=0.72) and without (P=0.33) dementia could be detected. The average aluminum concentration among cases with Alzheimer’s disease was also similar to the values of hip fracture patients with other types of dementia (P=0.47). Odds ratios of hip fracture for each quartile of aluminum content in bone were also estimated to detect non-linear effects, but we did not find any statistically significant association remaining after age and sex adjustment. Thus, our results indicate that we accumulate aluminum in bone over our life span, but this does not seem to be of major pathogenetic significance for the occurrence of hip fracture or dementia.
Literatur
2.
Zurück zum Zitat Varo P, Koivistoinen P (1980) Mineral element composition of Finish foods. Acta Agric Scand 22:161–171 Varo P, Koivistoinen P (1980) Mineral element composition of Finish foods. Acta Agric Scand 22:161–171
3.
Zurück zum Zitat Drüeke TB (2002) Intestinal absorption of aluminum in renal failure. Nephrol Dial Transplant 17 [Suppl 2]:13–16 Drüeke TB (2002) Intestinal absorption of aluminum in renal failure. Nephrol Dial Transplant 17 [Suppl 2]:13–16
4.
Zurück zum Zitat Priest ND (1999) Aluminum. Occurrence and toxicity. In: Sadler JJ, Caballero B (eds) Encyclopedia of human nutrition. Academic Press, San Diego, pp 59–66 Priest ND (1999) Aluminum. Occurrence and toxicity. In: Sadler JJ, Caballero B (eds) Encyclopedia of human nutrition. Academic Press, San Diego, pp 59–66
5.
Zurück zum Zitat Yokel RA, McNamara PJ (2001) Aluminum toxicokinetics: an updated minireview. Pharmacol Toxicol 88:159–167CrossRefPubMed Yokel RA, McNamara PJ (2001) Aluminum toxicokinetics: an updated minireview. Pharmacol Toxicol 88:159–167CrossRefPubMed
6.
Zurück zum Zitat Pérez-Granados AM, Vaquero MP (2002) Silicon, aluminum, arsenic and lithium: essentiality and human health implications. J Nutr Health Aging 6:154–162PubMed Pérez-Granados AM, Vaquero MP (2002) Silicon, aluminum, arsenic and lithium: essentiality and human health implications. J Nutr Health Aging 6:154–162PubMed
7.
Zurück zum Zitat Priest ND (2004) The biological behaviour and bioavailability of aluminum in man, with special reference to studies employing aluminum-26 as a tracer: review and study update. J Environ Monit 6:375–403CrossRefPubMed Priest ND (2004) The biological behaviour and bioavailability of aluminum in man, with special reference to studies employing aluminum-26 as a tracer: review and study update. J Environ Monit 6:375–403CrossRefPubMed
8.
Zurück zum Zitat Moore PB, Day JP, Taylor GA, Ferrier IN, Fifield LK, Edwardson JA (2000) Absorption of aluminum-26 in Alzheimer’s disease, measured using accelerator mass spectrometry. Dement Geriatr Cognit Disord 11:66–69CrossRef Moore PB, Day JP, Taylor GA, Ferrier IN, Fifield LK, Edwardson JA (2000) Absorption of aluminum-26 in Alzheimer’s disease, measured using accelerator mass spectrometry. Dement Geriatr Cognit Disord 11:66–69CrossRef
9.
Zurück zum Zitat Taylor GA, Ferrier IN, McLoughlin IJ, Fairbairn AF, McKeith IG, Lett D, Edwardson JA (1992) Gastrointestinal absorption of aluminum in Alzheimer’s disease: response to aluminum citrate. Age Ageing 21:81–90PubMed Taylor GA, Ferrier IN, McLoughlin IJ, Fairbairn AF, McKeith IG, Lett D, Edwardson JA (1992) Gastrointestinal absorption of aluminum in Alzheimer’s disease: response to aluminum citrate. Age Ageing 21:81–90PubMed
10.
Zurück zum Zitat Alfrey AC (1987) Aluminum metabolism and toxicity in uremia. J UOEH [Suppl] 9:123–132 Alfrey AC (1987) Aluminum metabolism and toxicity in uremia. J UOEH [Suppl] 9:123–132
11.
Zurück zum Zitat Alfrey AC, LeGendre GR, Kaehny WD (1976) The dialysis encephalopathy syndrome. Possible aluminum intoxication. N Engl J Med 294:184–188PubMed Alfrey AC, LeGendre GR, Kaehny WD (1976) The dialysis encephalopathy syndrome. Possible aluminum intoxication. N Engl J Med 294:184–188PubMed
12.
Zurück zum Zitat Berlyne GM (1970) Hyperaluminaemia from aluminum resins. Lancet 2:1253CrossRef Berlyne GM (1970) Hyperaluminaemia from aluminum resins. Lancet 2:1253CrossRef
13.
Zurück zum Zitat Berlyne GM, Yagil R, Ari JB, Weinberger G, Knopf E, Danovitch GM (1972) Aluminum toxicity in rats. Lancet 1:564–568CrossRefPubMed Berlyne GM, Yagil R, Ari JB, Weinberger G, Knopf E, Danovitch GM (1972) Aluminum toxicity in rats. Lancet 1:564–568CrossRefPubMed
14.
Zurück zum Zitat Cannata-Andia JB, Fernandez-Martin JL (2002) The clinical impact of aluminum overload in renal failure. Nephrol Dial Transplant 17 [Suppl 2]:9–12 Cannata-Andia JB, Fernandez-Martin JL (2002) The clinical impact of aluminum overload in renal failure. Nephrol Dial Transplant 17 [Suppl 2]:9–12
15.
Zurück zum Zitat Hewitt CD, Savory J, Wills MR (1990) Aspects of aluminum toxicity. Clin Lab Med 10:403–422PubMed Hewitt CD, Savory J, Wills MR (1990) Aspects of aluminum toxicity. Clin Lab Med 10:403–422PubMed
16.
17.
Zurück zum Zitat Parkinson IS, Ward MK, Feest TG, Fawcett RW, Kerr DN (1979) Fracturing dialysis osteodystrophy and dialysis encephalopathy. An epidemiological survey. Lancet 1:406–409CrossRefPubMed Parkinson IS, Ward MK, Feest TG, Fawcett RW, Kerr DN (1979) Fracturing dialysis osteodystrophy and dialysis encephalopathy. An epidemiological survey. Lancet 1:406–409CrossRefPubMed
18.
Zurück zum Zitat Sherrard DJ (1974) Letter: the myth of aluminum toxicity. N Engl J Med 290:750 Sherrard DJ (1974) Letter: the myth of aluminum toxicity. N Engl J Med 290:750
19.
Zurück zum Zitat Ward MK, Feest TG, Ellis HA, Parkinson IS, Kerr DN (1978) Osteomalacic dialysis osteodystrophy: evidence for a water-borne aetiological agent, probably aluminum. Lancet 1:841–845CrossRefPubMed Ward MK, Feest TG, Ellis HA, Parkinson IS, Kerr DN (1978) Osteomalacic dialysis osteodystrophy: evidence for a water-borne aetiological agent, probably aluminum. Lancet 1:841–845CrossRefPubMed
20.
Zurück zum Zitat Mjoberg B (1989) Aluminum-induced hip fractures: a hypothesis. J Bone Joint Surg Br 71:538PubMed Mjoberg B (1989) Aluminum-induced hip fractures: a hypothesis. J Bone Joint Surg Br 71:538PubMed
21.
Zurück zum Zitat Mjoberg B, Hellquist E, Mallmin H, Lindh U (1997) Aluminum, Alzheimer’s disease and bone fragility. Acta Orthop Scand 68:511–514PubMed Mjoberg B, Hellquist E, Mallmin H, Lindh U (1997) Aluminum, Alzheimer’s disease and bone fragility. Acta Orthop Scand 68:511–514PubMed
22.
Zurück zum Zitat Klein GL (1995) Aluminum in parenteral solutions revisited—again. Am J Clin Nutr 61:449–456PubMed Klein GL (1995) Aluminum in parenteral solutions revisited—again. Am J Clin Nutr 61:449–456PubMed
23.
Zurück zum Zitat Ott SM, Maloney NA, Klein GL, Alfrey AC, Ament ME, Coburn JW, Sherrard DJ (1983) Aluminum is associated with low bone formation in patients receiving chronic parenteral nutrition. Ann Intern Med 98:910–914PubMed Ott SM, Maloney NA, Klein GL, Alfrey AC, Ament ME, Coburn JW, Sherrard DJ (1983) Aluminum is associated with low bone formation in patients receiving chronic parenteral nutrition. Ann Intern Med 98:910–914PubMed
24.
Zurück zum Zitat Vargas JH, Klein GL, Ament ME, Ott SM, Sherrard DJ, Horst RL, Berquist WE, Alfrey AC, Slatopolsky E, Coburn JW (1988) Metabolic bone disease of total parenteral nutrition: course after changing from casein to amino acids in parenteral solutions with reduced aluminum content. Am J Clin Nutr 48:1070–1078PubMed Vargas JH, Klein GL, Ament ME, Ott SM, Sherrard DJ, Horst RL, Berquist WE, Alfrey AC, Slatopolsky E, Coburn JW (1988) Metabolic bone disease of total parenteral nutrition: course after changing from casein to amino acids in parenteral solutions with reduced aluminum content. Am J Clin Nutr 48:1070–1078PubMed
25.
Zurück zum Zitat Bush VJ, Moyer TP, Batts KP, Parisi JE (1995) Essential and toxic element concentrations in fresh and formalin-fixed human autopsy tissues. Clin Chem 41:284–294PubMed Bush VJ, Moyer TP, Batts KP, Parisi JE (1995) Essential and toxic element concentrations in fresh and formalin-fixed human autopsy tissues. Clin Chem 41:284–294PubMed
26.
Zurück zum Zitat Tahán JE, Granadillo VA, Romero RA (1994) Electrothermal atomic absorption spectrometric determination of Al, Cu, Fe, Pb, V and Zn in clinical samples and in certified environmental reference materials. Anal Chim Acta 295:187–197CrossRef Tahán JE, Granadillo VA, Romero RA (1994) Electrothermal atomic absorption spectrometric determination of Al, Cu, Fe, Pb, V and Zn in clinical samples and in certified environmental reference materials. Anal Chim Acta 295:187–197CrossRef
27.
Zurück zum Zitat Tang S, Parsons PJ, Perl D (1999) Longitudinal and lateral variations in the aluminum concentration of selected caprine, bovine, and human bone samples. Biol Trace Elem Res 68:267–279PubMed Tang S, Parsons PJ, Perl D (1999) Longitudinal and lateral variations in the aluminum concentration of selected caprine, bovine, and human bone samples. Biol Trace Elem Res 68:267–279PubMed
28.
Zurück zum Zitat Campbell A (2002) The potential role of aluminum in Alzheimer’s disease. Nephrol Dial Transplant 17 [Suppl 2]:17–20 Campbell A (2002) The potential role of aluminum in Alzheimer’s disease. Nephrol Dial Transplant 17 [Suppl 2]:17–20
29.
Zurück zum Zitat Campbell A, Becaria A, Lahiri DK, Sharman K, Bondy SC (2004) Chronic exposure to aluminum in drinking water increases inflammatory parameters selectively in the brain. J Neurosci Res 75:565–572CrossRefPubMed Campbell A, Becaria A, Lahiri DK, Sharman K, Bondy SC (2004) Chronic exposure to aluminum in drinking water increases inflammatory parameters selectively in the brain. J Neurosci Res 75:565–572CrossRefPubMed
30.
Zurück zum Zitat Foster HD (2002) Why the preeminent risk factor in sporadic Alzheimer’s disease cannot be genetic. Med Hypotheses 59:57–61CrossRefPubMed Foster HD (2002) Why the preeminent risk factor in sporadic Alzheimer’s disease cannot be genetic. Med Hypotheses 59:57–61CrossRefPubMed
31.
Zurück zum Zitat Grant WB, Campbell A, Itzhaki RF, Savory J (2002) The significance of environmental factors in the etiology of Alzheimer’s disease. J Alzheimer Dis 4:179–189 Grant WB, Campbell A, Itzhaki RF, Savory J (2002) The significance of environmental factors in the etiology of Alzheimer’s disease. J Alzheimer Dis 4:179–189
32.
Zurück zum Zitat Matsuzaki S, Manabe T, Katayama T, Nishikawa A, Yanagita T, Okuda H, Yasuda Y, Miyata S, Meshitsuka S, Tohyama M (2004) Metals accelerate production of the aberrant splicing isoform of the presenilin-2. J Neurochem 88:1345–1351PubMed Matsuzaki S, Manabe T, Katayama T, Nishikawa A, Yanagita T, Okuda H, Yasuda Y, Miyata S, Meshitsuka S, Tohyama M (2004) Metals accelerate production of the aberrant splicing isoform of the presenilin-2. J Neurochem 88:1345–1351PubMed
33.
Zurück zum Zitat Pedersen NL, Gatz M, Berg S, Johansson B (2004) How heritable is Alzheimer’s disease late in life? Findings from Swedish twins. Ann Neurol 55:180–185CrossRefPubMed Pedersen NL, Gatz M, Berg S, Johansson B (2004) How heritable is Alzheimer’s disease late in life? Findings from Swedish twins. Ann Neurol 55:180–185CrossRefPubMed
34.
Zurück zum Zitat Pedersen NL, Posner SF, Gatz M (2001) Multiple-threshold models for genetic influences on age of onset for Alzheimer disease: findings in Swedish twins. Am J Med Genet 105:724–728CrossRefPubMed Pedersen NL, Posner SF, Gatz M (2001) Multiple-threshold models for genetic influences on age of onset for Alzheimer disease: findings in Swedish twins. Am J Med Genet 105:724–728CrossRefPubMed
35.
Zurück zum Zitat Buchner DM, Larson EB (1987) Falls and fractures in patients with Alzheimer-type dementia. JAMA 257:1492–1495CrossRefPubMed Buchner DM, Larson EB (1987) Falls and fractures in patients with Alzheimer-type dementia. JAMA 257:1492–1495CrossRefPubMed
36.
Zurück zum Zitat Gruber-Baldini AL, Zimmerman S, Morrison RS, Grattan LM, Hebel JR, Dolan MM, Hawkes W, Magaziner J (2003) Cognitive impairment in hip fracture patients: timing of detection and longitudinal follow-up. J Am Geriatr Soc 51:1227–1236CrossRefPubMed Gruber-Baldini AL, Zimmerman S, Morrison RS, Grattan LM, Hebel JR, Dolan MM, Hawkes W, Magaziner J (2003) Cognitive impairment in hip fracture patients: timing of detection and longitudinal follow-up. J Am Geriatr Soc 51:1227–1236CrossRefPubMed
37.
Zurück zum Zitat Walter LC, Lui LY, Eng C, Covinsky KE (2003) Risk of hip fracture in disabled community-living older adults. J Am Geriatr Soc 51:50–55CrossRefPubMed Walter LC, Lui LY, Eng C, Covinsky KE (2003) Risk of hip fracture in disabled community-living older adults. J Am Geriatr Soc 51:50–55CrossRefPubMed
38.
Zurück zum Zitat Weller I, Schatzker J (2004) Hip fractures and Alzheimer’s disease in elderly institutionalized Canadians. Ann Epidemiol 14:319–324CrossRefPubMed Weller I, Schatzker J (2004) Hip fractures and Alzheimer’s disease in elderly institutionalized Canadians. Ann Epidemiol 14:319–324CrossRefPubMed
39.
Zurück zum Zitat Cockcroft DW, Gault MH (1976) Prediction of creatinine clearance from serum creatinine. Nephron 16:31–41PubMed Cockcroft DW, Gault MH (1976) Prediction of creatinine clearance from serum creatinine. Nephron 16:31–41PubMed
40.
Zurück zum Zitat Hellstrom HO, Lindh U, Mjoberg B (2000) Measurement accuracy of aluminum content in bone. Ups J Med Sci 105:67–71PubMed Hellstrom HO, Lindh U, Mjoberg B (2000) Measurement accuracy of aluminum content in bone. Ups J Med Sci 105:67–71PubMed
41.
Zurück zum Zitat Cummings SR, Melton LJ (2002) Epidemiology and outcomes of osteoporotic fractures. Lancet 359:1761–1767CrossRefPubMed Cummings SR, Melton LJ (2002) Epidemiology and outcomes of osteoporotic fractures. Lancet 359:1761–1767CrossRefPubMed
42.
Zurück zum Zitat Gomez-Alonso C, Menendez-Rodriguez P, Virgos-Soriano MJ, Fernandez-Martin JL, Fernandez-Coto MT, Cannata-Andia JB (1999) Aluminum-induced osteogenesis in osteopenic rats with normal renal function. Calcif Tissue Int 64:534–541CrossRefPubMed Gomez-Alonso C, Menendez-Rodriguez P, Virgos-Soriano MJ, Fernandez-Martin JL, Fernandez-Coto MT, Cannata-Andia JB (1999) Aluminum-induced osteogenesis in osteopenic rats with normal renal function. Calcif Tissue Int 64:534–541CrossRefPubMed
43.
Zurück zum Zitat Delmas PD, Recker RR, Chesnut CH 3, Skag A, Stakkestad JA, Emkey R, Gilbride J, Schimmer RC, Christiansen C (2004) Daily and intermittent oral ibandronate normalize bone turnover and provide significant reduction in vertebral fracture risk: results from the BONE study. Osteoporos Int 15:792–798CrossRefPubMed Delmas PD, Recker RR, Chesnut CH 3, Skag A, Stakkestad JA, Emkey R, Gilbride J, Schimmer RC, Christiansen C (2004) Daily and intermittent oral ibandronate normalize bone turnover and provide significant reduction in vertebral fracture risk: results from the BONE study. Osteoporos Int 15:792–798CrossRefPubMed
44.
Zurück zum Zitat Quarles LD (1991) Paradoxical toxic and trophic osseous actions of aluminum: potential explanations. Miner Electrolyte Metab 17:233–239PubMed Quarles LD (1991) Paradoxical toxic and trophic osseous actions of aluminum: potential explanations. Miner Electrolyte Metab 17:233–239PubMed
45.
Zurück zum Zitat Quarles LD, Gitelman HJ, Drezner MK (1989) Aluminum-induced de novo bone formation in the beagle. A parathyroid hormone-dependent event. J Clin Invest 83:1644–1650PubMed Quarles LD, Gitelman HJ, Drezner MK (1989) Aluminum-induced de novo bone formation in the beagle. A parathyroid hormone-dependent event. J Clin Invest 83:1644–1650PubMed
46.
Zurück zum Zitat Quarles LD, Murphy G, Vogler JB, Drezner MK (1990) Aluminum-induced neo-osteogenesis: a generalized process affecting trabecular networking in the axial skeleton. J Bone Miner Res 5:625–635PubMed Quarles LD, Murphy G, Vogler JB, Drezner MK (1990) Aluminum-induced neo-osteogenesis: a generalized process affecting trabecular networking in the axial skeleton. J Bone Miner Res 5:625–635PubMed
47.
Zurück zum Zitat Rodriguez M, Felsenfeld AJ, Llach F (1990) Aluminum administration in the rat separately affects the osteoblast and bone mineralization. J Bone Miner Res 5:59–67PubMed Rodriguez M, Felsenfeld AJ, Llach F (1990) Aluminum administration in the rat separately affects the osteoblast and bone mineralization. J Bone Miner Res 5:59–67PubMed
48.
Zurück zum Zitat Zhu JM, Huffer W, Alfrey AC (1990) Effect of aluminum on bone matrix inductive properties. Kidney Int 38:1141–1145PubMed Zhu JM, Huffer W, Alfrey AC (1990) Effect of aluminum on bone matrix inductive properties. Kidney Int 38:1141–1145PubMed
49.
Zurück zum Zitat Cumming RG, Klineberg RJ (1994) Aluminum in antacids and cooking pots and the risk of hip fractures in elderly people. Age Ageing 23:468–472PubMed Cumming RG, Klineberg RJ (1994) Aluminum in antacids and cooking pots and the risk of hip fractures in elderly people. Age Ageing 23:468–472PubMed
50.
Zurück zum Zitat O’Mahony D, Denton J, Templar J, O’Hara M, Day JP, Murphy S, Walsh JB, Coakley D (1995) Bone aluminum content in Alzheimer’s disease. Dementia 6:69–72PubMed O’Mahony D, Denton J, Templar J, O’Hara M, Day JP, Murphy S, Walsh JB, Coakley D (1995) Bone aluminum content in Alzheimer’s disease. Dementia 6:69–72PubMed
51.
Zurück zum Zitat Ganrot PO (1986) Metabolism and possible health effects of aluminum. Environ Health Perspect 65:363–441PubMed Ganrot PO (1986) Metabolism and possible health effects of aluminum. Environ Health Perspect 65:363–441PubMed
52.
Zurück zum Zitat D’Haese PC, Couttenye MM, Lamberts LV, Elseviers MM, Goodman WG, Schrooten I, Cabrera WE, De Broe ME (1999) Aluminum, iron, lead, cadmium, copper, zinc, chromium, magnesium, strontium, and calcium content in bone of end-stage renal failure patients. Clin Chem 45:1548–1556PubMed D’Haese PC, Couttenye MM, Lamberts LV, Elseviers MM, Goodman WG, Schrooten I, Cabrera WE, De Broe ME (1999) Aluminum, iron, lead, cadmium, copper, zinc, chromium, magnesium, strontium, and calcium content in bone of end-stage renal failure patients. Clin Chem 45:1548–1556PubMed
53.
Zurück zum Zitat Navarro JA, Granadillo VA, Salgado O, Rodriguez-Iturbe B, Garcia R, Delling G, Romero RA (1992) Bone metal content in patients with chronic renal failure. Clin Chim Acta 211:133–142CrossRefPubMed Navarro JA, Granadillo VA, Salgado O, Rodriguez-Iturbe B, Garcia R, Delling G, Romero RA (1992) Bone metal content in patients with chronic renal failure. Clin Chim Acta 211:133–142CrossRefPubMed
54.
Zurück zum Zitat Paakari P, Anker Nielsen A, Lauritsen P, Morkore H, Voipio T, Sigfússon E, Litleskare I, Ericsson O, Nielsen J (2004) Medicines Consumption in the Nordic Countries 1999–2003, http://www.nom-nos.dk/Medicinebook/medicines%20consumption.pdf. Schultz Information, Albertslund, Denmark Paakari P, Anker Nielsen A, Lauritsen P, Morkore H, Voipio T, Sigfússon E, Litleskare I, Ericsson O, Nielsen J (2004) Medicines Consumption in the Nordic Countries 1999–2003, http://​www.​nom-nos.​dk/​Medicinebook/​medicines%20consumption.pdf. Schultz Information, Albertslund, Denmark
55.
Zurück zum Zitat Pennington JA (1988) Aluminum content of foods and diets. Food Addit Contam 5:161–232PubMed Pennington JA (1988) Aluminum content of foods and diets. Food Addit Contam 5:161–232PubMed
Metadaten
Titel
The aluminum content of bone increases with age, but is not higher in hip fracture cases with and without dementia compared to controls
verfasst von
Hans-Olov Hellström
Bengt Mjöberg
Hans Mallmin
Karl Michaëlsson
Publikationsdatum
01.12.2005
Verlag
Springer-Verlag
Erschienen in
Osteoporosis International / Ausgabe 12/2005
Print ISSN: 0937-941X
Elektronische ISSN: 1433-2965
DOI
https://doi.org/10.1007/s00198-005-1981-6

Weitere Artikel der Ausgabe 12/2005

Osteoporosis International 12/2005 Zur Ausgabe

Arthropedia

Grundlagenwissen der Arthroskopie und Gelenkchirurgie. Erweitert durch Fallbeispiele, Videos und Abbildungen. 
» Jetzt entdecken

Update Orthopädie und Unfallchirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.